(Q31003607)

English

PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

0 references

PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Silvia Minozzi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Paolo Castellucci

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Ken Herrmann

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Bernd Joachim Krause

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

55-69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26450693%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Imaging biomarkers in prostate cancer: role of PET/CT and MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

[11C]choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Is there a role for ¹¹C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

11C-choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

PSA doubling time for prediction of [(11)C]choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Dual tracer 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

FDG PET-CT imaging for pre operative staging in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Prostate cancer: Identifying sites of recurrence with choline-PET-CT imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

PET imaging in prostate cancer: focus on prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Prostate-Specific Antigen Velocity Versus Prostate-Specific Antigen Doubling Time for Prediction of 11C Choline PET/CT in Prostate Cancer Patients With Biochemical Failure After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-015-3202-7

21 January 2018

Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of diagnostic tests when there is no gold standard. A review of methods.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experience with carbon-11 choline positron emission tomography in prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of ¹¹C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[11C]choline PET for the intraprostatic tumor characterization and localization in recurrent prostate cancer after EBRT

1 reference

https://pubmed.ncbi.nlm.nih.gov/26450693

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31003607&oldid=2195058893"